Jeffrey Robert Ajer - Mar 15, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: EVP, Chief Commercial Officer
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Stock symbol: BMRN
Transactions as of: Mar 15, 2022
Transactions value $: -$762,764
Form type: 4
Date filed: 3/17/2022, 09:11 PM
Previous filing: Mar 10, 2022
Next filing: Mar 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+11.9K	+18.31%	$0.00	77.2K	Mar 15, 2022	Direct	F1
transaction	BMRN	Common Stock	Tax liability	-$659K	-8.42K	-10.91%	$78.27	68.7K	Mar 15, 2022	Direct
transaction	BMRN	Common Stock	Tax liability	-$104K	-1.29K	-1.87%	$80.72	67.5K	Mar 16, 2022	Direct

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to buy Common Stock)	Award	$0	+28.7K		$0.00	28.7K	Mar 15, 2022	Common Stock	28.7K	$78.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on March 15, 2022. Price not applicable.
F2	Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.